Catalyst Pharmaceuticals Inc
XBER:CN2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Catalyst Pharmaceuticals Inc
XBER:CN2
|
US |
|
Shimao Services Holdings Ltd
F:5GO
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CN2's stock price target?
Not Available
CN2 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Revenue over the next 8 years is 7%.
What is the Gross Profit forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
9%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 9%.
What is the Net Income forecast for Catalyst Pharmaceuticals Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 5 years is 26%.
